SHIFT Newsroom · GLOBAL
Expert Panel Review of Resmetirom and Semaglutide for MASH-Related Fibrosis
An international expert panel has reviewed the use of resmetirom and semaglutide in managing MASH-related fibrosis, providing a clinical practice update.
An international expert panel has published a review on the use of resmetirom and semaglutide for MASH-related fibrosis. The review provides a clinical practice update, but the current UK regulatory status and NHS availability of these medicines are unknown.
What this means in the UK
The review may inform future treatment options for UK patients with MASH-related fibrosis, although the current UK regulatory status and NHS availability of these medicines are unknown.
Known facts
- An international expert panel has reviewed the use of resmetirom and semaglutide for MASH-related fibrosis.